He said contrary to fears that the anti-malaria vaccines could come with some difficulties, credible information received from the Ghana Health Service (GHS) indicated that nothing of the sort had been recorded since the roll-out began in April this year.
Mr Abban revealed this in an interview with the Daily Graphic at the opening of the 4th annual West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) Conference at Legon in Accra yesterday.
“The pilot exercise has been successful so far since information from the Ghana Health Service indicates that the initial doubts people raised have been completely cleared.
“We have not had any negative incident anywhere. No new parent is also challenging the Ministry of Health against administering the vaccines to their children,” he said.
He urged all parents in the areas where the vaccines were being piloted to cooperate because it would protect their babies against the malaria parasite.
The pilot of the world’s first anti-malaria vaccine for children aged between six months and two years was begun in Ghana on April 30, 2019.Known as RTS, S or Mosquirix, the vaccine is being introduced as a boost to Ghana’s National Anti-Malaria Programme.
The pilot is currently being conducted in 33 districts across the Bono, Bono East, Ahafo, Central, Volta and Oti regions.
Prior to the commencement of the exercise, a section of the public expressed doubts about the efficacy of the vaccines, fearing that it could affect the health of babies who would be introduced to it.